Effect of chemokine receptors CCR7 on disseminated behavior of Human T cell lymphoma: Clinical and experimental study

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Yang, Jing ^a   Wang, Shengyi ^a   Zhao, Guofan ^a   Sun, Baocun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GELATINASE A; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SECONDARY LYMPHOID TISSUE CHEMOKINE; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CLINICAL STUDY; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISEASE COURSE; DISSEMINATED CANCER; EXPERIMENTAL STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL LINE; LYMPHOID HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA; WESTERN BLOTTING; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSCELLULAR CELL MIGRATION; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JURKAT CELLS; LYMPHOMA, T-CELL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CCR7; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCELLULAR CELL MIGRATION;

EID: 79955666386     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-51     Document Type: Article

References (30)

1. Chemokines: key players in cancer. M Arya HR Patel M Williamson, Curr Med Res Opin 2003 19 557 64 10.1185/030079903125002216 14594528 (Pubitemid 37122049)
2. Secondary lymphoid tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. R Yoshida M Nagira M Kitaura N Imagawa T Imai O Yoshie, Biol Chem 1998 273 12 7118 7122 10.1074/jbc.273.12.7118 (Pubitemid 28160383)
3. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. MC Dieu B Vanbervliet A Vicari JM Bridon E Oldham S At-Yahia F Brière A Zlotnik S Lebecque C Caux, Exp Med 1998 188 373 86 10.1084/jem.188.2.373 (Pubitemid 28357765)
4. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells:critical role in migration from the tumor site to draining lymph nodes. M Hirao N Onai K Hiroishi SC Watkins K Matsushima PD Robbins MT Lotze H Tahara, Cancer Res 2000 60 2209 17 10786686 (Pubitemid 30225185)
5. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Y Ding Y Shimada M Maeda A Kawabe J Kaganoi I Komoto Y Hashimoto M Miyake H Hashida M Imamura, Clin Cancer Res 2003 9 3406 12 12960129 (Pubitemid 37082736)
6. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. H Takeuchi A Fujimoto M Tanaka T Yamano E Hsueh DS Hoon, Clin Cancer Res 2004 10 7 2351 2358 10.1158/1078-0432.CCR-03-0195 15073111 (Pubitemid 38445693)
7. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. H Saeki AM Moore MJ Brown ST Hwang, J Immunol 1999 162 2472 75 10072485 (Pubitemid 29309263)
8. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. T Mori R Doi M Koizumi E Toyoda D Ito K Kami T Masui K Fujimoto H Tamamura K Hiramatsu N Fujii M Imamura, Mol Cancer Ther 2004 3 29 37 10.4161/cbt.3.1.547 14749473 (Pubitemid 39193676)
9. Tannic acid prevents angiogenesis in vivo by inhibiting CXCR4/SDF-1 a binding in breast cancer cells. DD Twitchell NR London DP Tomer S Tomer BK Murray KL O'Neill, Proc AACR 2004 45 bstract 51
10. Involvement of chemokine receptors in breast cancer metastasis. A Müller B Homey H Soto N Ge D Catron ME Buchanan T McClanahan E Murphy W Yuan SN Wagner JL Barrera A Mohar E Verstegui A Zlotnik, Nature 2001 410 50 6 10.1038/35065016 11242036 (Pubitemid 32225831)
11. Over expression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. I Takanami, Int J Cancer 2003 105 2 186 189 10.1002/ijc.11063 12673677 (Pubitemid 36505319)
12. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. K Mashino N Sadanaga H Yamaguchi F Tanaka M Ohta K Shibuta H Inoue M Mori, Cancer Res 2002 62 2937 41 12019175 (Pubitemid 34525782)
13. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. HE Wiley EB Gonzalez W Maki MT Wu ST Hwang, J Natl Cancer Inst 2001 93 1638 43 10.1093/jnci/93.21.1638 11698568 (Pubitemid 33094871)
14. CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. G Henning L Ohl T Junt P Reiterer V Brinkmann H Nakano W Hohenberger M Lipp R Förster, J Exp Med 2001 194 1875 81 10.1084/jem.194.12.1875 11748287 (Pubitemid 34028665)
15. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. T Okada VN Ngo EH Ekland R Förster M Lipp DR Littman JG Cyster, J Exp Med 2002 196 65 75 10.1084/jem.20020201 12093871 (Pubitemid 34747312)
16. CR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. JV Stein SF Soriano C M'rini C Nombela-Arrieta GG de Buitrago JM Rodríguez-Frade M Mellado JP Girard C Martínez-AC, Blood 2003 101 38 44 10.1182/blood-2002-03-0841 12393730 (Pubitemid 36025884)
17. Construction of eukaryotic expression vector of murine SLC gene and characterization of its chemotactic function. F Ma SR Zhang L Ning WX Sun X Liang XY Zhang M Fu C Lin, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2003 19 6 528 30 15182640
18. CCR7 signaling as an essential regulator of CNS infiltration in T-cell leukemia. S Buonamici T Trimarchi MG Ruocco L Reavie S Cathelin BG Mar A Klinakis Y Lukyanov JC Tseng F Sen E Gehrie M Li E Newcomb J Zavadil D Meruelo M Lipp S Ibrahim A Efstratiadis D Zagzag JS Bromberg ML Dustin I Aifantis, Nature 2009 459 7249 1000 4 10.1038/nature08020 19536265
19. Molecular biology of cancer: invasion and metastases. WG Stetler-Stevenson DE Kleiner, Philadelphia: Lippincott & Wilkins 2001 123 36
20. Chemokines and anti-cancer immunotherapy: Anti-tumor effect of EBL1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC). T Nomura H Hasegawa, Anticancer Res 2000 20 6A 4073 4080 11131675
21. Cellular function of phosphoinositide-3-kinases: imp lications for development, homeostasis, and cancer. R Katso K Okkenhaug K Ahmadi S White J Timms MD Waterfield, Annu Rev Cell Dev Biol 2001 17 615 675 10.1146/annurev. cellbio.17.1.615 11687500
22. Akt2 expression correlates with prognosis of human hepatocellular carcinoma. X Xu M Sakon H Nagano N Hiraoka H Yamamoto N Hayashi K Dono S Nakamori K Umeshita Y Ito N Matsuura M Monden, Oncol Rep 2005 11 25 32
23. Prognostic significance of activated akt expression in pancreatic ductal adenocarcinoma. S Yamamoto Y Tomita Y Hoshida T Morooka H Nagano K Dono K Umeshita M Sakon O Ishikawa H Ohigashi S Nakamori M Monden K Aozasa, Clin Cancer Res 2004 10 2846 2850 10.1158/1078-0432.CCR-02-1441 15102693 (Pubitemid 38509164)
24. Activation of AKT kinases in cancer: implications for therapeutic targeting. A Bellacosa CC Kumar A Di Cristofano JR Testa, Adv Cancer Res 2005 94 29 86 16095999 (Pubitemid 41202364)
25. Perturbations of the AKT signaling pathway in human cancer. DA Altomare JR Testa, Oncogene 2005 24 7455 7464 10.1038/sj.onc.1209085 16288292 (Pubitemid 41637985)
26. The protein kinase B/Akt signaling pathway in human malignancy. KM Nicholson NG Anderson, Cell Signal 2002 14 381 395 10.1016/S0898-6568(01)00271-6 11882383 (Pubitemid 34214843)
27. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. N Snchez-Snchez L Riol-Blanco G de la Rosa A Puig-Kröger J García-Bordas D Martín N Longo A Cuadrado C Cabãas AL Corbí P Snchez-Mateos JL Rodríguez-Fernndez, Blood 2004 104 3 619 10.1182/blood-2003-11-3943 15059845
28. Matrix metalloproteinases in tumor invasion: role for cell migration. K Nabeshima T Inoue Y Shimao T Sameshima, Pathol Annual 2002 52 4 255 264 (Pubitemid 34587810)
29. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgekin's lymphoma. K Sakata M Satoh M Someya H Asanuma H Nagakura A Oouchi K Nakata K Kogawa K Koito M Hareyama T Himi, Cancer 2004 100 356 365 10.1002/cncr.11905 14716772 (Pubitemid 38063646)
30. Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. M Arlt C Kopitz C Pennington KL Watson HW Krell W Bode B Gansbacher R Khokha DR Edwards A Krüger, Cancer Res 2002 62 19 5543 5550 12359766